Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

Chronic hepatitis B

2007 • 3,079 citations

A One-Year Trial of Lamivudine for Chronic Hepatitis B

1998 • 1,779 citations

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

2000 • 1,246 citations

LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES

1999 • 1,119 citations

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1993 • 1,011 citations

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

2000 • 893 citations

Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B

1996 • 821 citations

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

2000 • 708 citations

Chronic hepatitis B

2001 • 694 citations

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1998 • 571 citations

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1999 • 516 citations

Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

2000 • 513 citations

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

2000 • 503 citations

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

2000 • 426 citations

Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

2001 • 370 citations

Clinical Trial of Lamivudine in Children with Chronic Hepatitis B

2002 • 315 citations

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

1999 • 300 citations

Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium

2000 • 170 citations

Immunomodulation and Therapeutic Effects of the Oral Use of Interferon-alpha: Mechanism of Action

1999 • 134 citations

Quantitation of Hepatitis B Viremia and Emergence of YMDD Variants in Patients with Chronic Hepatitis B Treated with Lamivudine

1999 • 123 citations

Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine

1992 • 119 citations

Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome

1999 • 87 citations

Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects

1996 • 83 citations

Hepatitis B viral resistance: mechanisms and diagnosis

2003 • 81 citations

New nucleoside analogues for chronic hepatitis B.

1995 • 55 citations

Effect of the prokinetic agent, erythromycin, in the richardson ground squirrel model of cholesterol gallstone disease

1998 • 45 citations

Mechanism of Interferon Action: Identification of Essential Positions within the Novel 15-Base-Pair KCS Element Required for Transcriptional Activation of the RNA-Dependent Protein Kinase pkr Gene

1998 • 41 citations

Mechanism of Interferon Action: Functional Characterization of Positive and Negative Regulatory Domains That Modulate Transcriptional Activation of the Human RNA-Dependent Protein KinasePkrPromoter

1999 • 38 citations

Comparative study of three doses of interferon‐α2a in chronic active hepatitis B

1994 • 35 citations

Hepatitis B virus resistance to antivirals: clinical implications and management

2003 • 23 citations

Spotlight on Peginterferon-??-2a (40KD) in Chronic Hepatitis C*

2002 • 10 citations